A European technology company preparing its Swiss listing discovers that the documentation requirements extend far beyond a standard prospectus. Swiss capital markets law demands precise disclosure of risk factors, governance structures, and financial history. and the review process at the supervisory authority can stall a transaction by weeks if a single element is incomplete. For international businesses, the gap between expectation and Swiss regulatory reality is one of the most common sources of delay and cost overrun in cross-border capital markets transactions.
Capital markets in Switzerland are governed primarily by Swiss financial markets legislation, which establishes a rigorous regime for securities offerings, listing requirements, and ongoing disclosure obligations. Companies seeking to access Swiss public markets must file an approved prospectus with FINMA or the competent reviewing body and satisfy the admission criteria of the relevant exchange. The process from mandate to listing typically spans three to six months, depending on transaction complexity and the readiness of the issuer's documentation.
This page explains the principal legal instruments available to international issuers in Switzerland, the procedural steps and timelines involved. The practical pitfalls that most frequently affect cross-border clients. Additionally, the strategic considerations that arise when a Swiss capital markets transaction intersects with EU and Portuguese regulatory systems.
The Swiss capital markets regulatory setting
Switzerland operates one of the most developed and internationally recognised capital markets environments in Europe. Its legal system is built on a distinct civil law tradition, anchored in Swiss financial markets legislation and the Swiss Code of Obligations. These two bodies of law work in parallel: financial markets legislation governs public offerings, prospectus approval. Additionally, market conduct. While the Swiss Code of Obligations governs the corporate instruments through which securities are issued. including shares in an Aktiengesellschaft (AG, the Swiss public limited company) and interests in a Gesellschaft mit beschränkter Haftung (GmbH CH, the Swiss private limited company).
The Swiss Financial Market Supervisory Authority (FINMA) is the primary regulatory body. It oversees issuers, financial intermediaries, and collective investment schemes. For listed companies, the SIX Swiss Exchange sets its own admission and continuing obligations, which run alongside the FINMA regime. The Bundesgericht (Federal Supreme Court of Switzerland) provides the highest judicial authority on disputes arising from capital markets transactions, and its rulings shape how practitioners interpret disclosure obligations and issuer liability.
Switzerland's regulatory system is deliberately calibrated to attract international capital. It is not a member of the European Union, but Swiss financial markets legislation is substantially aligned with EU standards in areas such as prospectus content and market abuse. This alignment matters for issuers who plan dual listings or who target EU-based investors alongside Swiss ones. At the same time, Switzerland retains its own approval processes and does not participate in the EU passporting regime for prospectuses. A prospectus approved in an EU member state cannot be used in Switzerland without adaptation and re-approval.
For companies incorporated or operating in the EU – including those with a Portuguese parent or subsidiary – the consequence is direct. An issuer that has already completed a prospectus for an EU offering must prepare a separate document for Switzerland, tailored to Swiss disclosure requirements. This is a structural feature of the Swiss system, not an administrative formality, and it has material cost and timeline implications for cross-border transactions.
Key instruments and procedures for Swiss capital markets transactions
Swiss capital markets law provides a set of well-defined instruments for raising capital from public and institutional investors. Understanding the applicable conditions, procedural steps, and realistic timelines for each is essential before committing resources to a transaction.
Public equity offerings and IPOs. An initial public offering (IPO) on the SIX Swiss Exchange is the most demanding capital markets procedure available in Switzerland. The issuer must prepare a prospectus that satisfies Swiss financial markets legislation and the SIX admission requirements. The prospectus must include audited financial statements, a description of the business, risk factors, and a detailed account of the intended use of proceeds. The reviewing body examines the document for completeness and accuracy. Review periods vary, but issuers should plan for a minimum of four to six weeks from submission of a substantially complete draft to formal approval. The entire process, from initial preparation through to first trading day, rarely takes fewer than four months and often extends to six months or more for complex issuers.
A company registered in the Handelsregister Schweiz (Swiss Commercial Register) as an AG is the standard vehicle for an IPO. The corporate formalities for share capital increases, board resolutions, and shareholder approval must all be completed in accordance with the Swiss Code of Obligations before the offering can proceed. Gaps in corporate documentation are among the most frequent causes of procedural delay at the exchange admission stage.
Debt capital markets and bond issuances. Swiss debt capital markets are deep and liquid. Corporate bonds, covered bonds, and structured notes are regularly issued by both Swiss and international issuers on the SIX Swiss Exchange or in the Swiss over-the-counter market. A public bond offering requires a prospectus or, for certain standardised instruments, an abbreviated disclosure document. Private placements to qualified investors can be executed under a lighter documentation regime, without full prospectus approval, provided the issuer meets the applicable investor categorisation thresholds set out in financial markets legislation.
The timeline for a rated investment-grade bond offering from a well-prepared issuer can be compressed to six to ten weeks. Issuers without an existing credit rating or with complex group structures should budget additional time for rating agency processes and structural due diligence.
Investment funds and collective investment schemes. Switzerland has a separate legislative regime for investment funds and collective investment schemes, administered by FINMA. An investment fund domiciled in Switzerland must be authorised by FINMA before it can be offered to Swiss investors. Foreign funds seeking distribution in Switzerland face additional requirements, including the appointment of a Swiss representative and paying agent. The authorisation process for a new Swiss fund typically takes three to five months. For foreign fund distribution approval, timelines depend on whether the fund's home jurisdiction has a recognised equivalence arrangement with Switzerland.
For clients interested in the broader financial structuring context, our practice on banking and finance matters in Switzerland addresses the lending and security structures that commonly accompany capital markets transactions.
Secondary offerings and rights issues. Listed companies in Switzerland regularly raise additional capital through secondary offerings and rights issues. These transactions require updated disclosure – typically a supplementary prospectus or an offering circular – and must comply with the pre-emption rights regime established under the Swiss Code of Obligations. Shareholders' pre-emption rights can be disapplied by a qualified shareholder vote, but the procedural requirements for that vote must be met precisely. Courts in Switzerland have consistently held that defects in the shareholder approval process can expose the board to claims by existing shareholders.
To receive a tailored assessment of your Swiss capital markets transaction, contact us at info@ferrazwhitmore.com.
Practical pitfalls for international issuers in Switzerland
International clients approaching Swiss capital markets for the first time frequently encounter a set of recurring difficulties. These are not always visible from a reading of the legislation alone.
Prospectus completeness at first submission. The reviewing body does not engage in iterative review as a matter of course. An incomplete submission restarts the clock. Issuers who submit before their financial statements are audited, or before their legal structure is fully documented, routinely face delays of four to eight additional weeks. The practical lesson is that all supporting documentation must be finalised before the prospectus is submitted, not during the review period.
Language requirements. Swiss financial markets legislation permits prospectuses in German, French, Italian, or English, subject to specific rules depending on the exchange segment and investor profile targeted. Many international issuers prepare English-language prospectuses without confirming whether a summary in a national language is required. A missing language version can prevent approval and delay the transaction by two to four weeks while a certified translation is prepared.
Corporate capacity and authorisation chains. Swiss capital markets transactions involving foreign issuers or foreign parent companies require careful verification of the authorisation chain. The transaction documents must demonstrate that every corporate approval – board resolutions, shareholder authorisations, power of attorney chains – has been validly granted under both Swiss law and the law of the issuer's home jurisdiction. In practice, the weakest link is often the home jurisdiction corporate formality, which practitioners in Switzerland note is frequently underestimated by foreign legal teams.
Market abuse and insider trading rules. Switzerland's market conduct rules impose strict obligations on issuers and their officers from the moment a transaction is in preparation. Any selective disclosure of material non-public information before the prospectus is approved and published can constitute a violation of Swiss market conduct legislation. International management teams accustomed to less stringent pre-announcement practices in other markets should receive specific guidance on Swiss market conduct obligations at the outset of a transaction.
Ongoing disclosure after listing. The admission of securities to trading on the SIX Swiss Exchange triggers a continuous disclosure regime. Ad hoc publicity obligations require immediate publication of any price-sensitive information. Many newly listed companies – particularly those whose management teams are based outside Switzerland – underestimate the speed and specificity required by this obligation. A failure to publish material information promptly can trigger enforcement action by the exchange and regulatory scrutiny from FINMA.
Cross-border dimensions: Switzerland, the EU, and Portugal
Switzerland's position outside the EU creates specific structural considerations for issuers who operate across both systems. These are not merely administrative. They affect transaction design, investor targeting, timeline, and cost from the outset.
The absence of EU prospectus passporting. As noted above, a prospectus approved in an EU member state – including Portugal – cannot be passported into Switzerland. The inverse is also true. An issuer completing a dual listing in Switzerland and in an EU market must prepare two distinct prospectus documents, each approved by the competent authority in its own jurisdiction. This doubles the review burden and requires careful coordination between the two regulatory processes to avoid conflicting timelines.
For issuers with a Portuguese connection. whether a Portuguese parent company, a subsidiary operating in Portugal. Alternatively. A shareholder base that includes Portuguese institutional investors. the interaction between Swiss capital markets legislation and Portuguese and EU securities law requires specific planning. Portugal's securities markets are regulated under EU legislation, and the disclosure and liability standards applicable to a Portuguese-listed company differ from those applicable to a Swiss-listed company in several respects. Clients managing a dual exposure should understand those differences before they commit to a transaction structure.
Our practice covering capital markets in Portugal provides a detailed account of the EU prospectus regime and the Portuguese regulatory process, which can assist in planning a coordinated cross-border transaction.
Tax treaty interaction. Switzerland has an extensive network of double taxation treaties, including with Portugal. Withholding tax on dividends and interest payments to foreign investors is a live issue in any Swiss equity or debt offering. The applicable treaty rate, the administrative procedure for claiming treaty relief, and the interaction with Swiss domestic withholding tax legislation all require analysis before the offering terms are finalised. Investors who fail to claim treaty relief in time are subject to Swiss withholding tax at the standard rate, which is materially higher than most treaty rates.
Investment fund distribution across borders. A Swiss-domiciled investment fund seeking to distribute to EU investors, or an EU fund seeking distribution approval in Switzerland, must navigate two separate regulatory systems. The Swiss representative and paying agent requirement applies regardless of the fund's EU authorisation status. Switzerland's bilateral arrangements with individual EU member states govern the recognition of fund documentation in each direction, and those arrangements are not uniform. The practical consequence is that a fund approved for distribution in Portugal is not automatically eligible for Swiss distribution, and the reverse approval process must be initiated separately.
Enforcement and dispute resolution. Disputes arising from Swiss capital markets transactions are generally subject to Swiss jurisdiction and Swiss law, unless the parties have contractually agreed to international arbitration. The Bundesgericht has jurisdiction over final appeals. International clients should be aware that Swiss civil procedure rules impose strict filing deadlines and evidence submission requirements that differ significantly from common law discovery-based systems. A business accustomed to English or US litigation practice will encounter a materially different procedural environment in Swiss courts.
For a tailored strategy on cross-border capital markets transactions involving Switzerland and EU jurisdictions, reach out to info@ferrazwhitmore.com.
Self-assessment checklist before initiating a Swiss capital markets transaction
A Swiss capital markets transaction is appropriate if the following conditions are present:
- The issuer is structured as an AG or has completed a conversion to an AG under Swiss corporate legislation prior to the offering.
- Audited financial statements are available for at least two full financial years and have been prepared in accordance with Swiss GAAP, IFRS, or a recognised equivalent standard.
- The issuer's corporate authorisation chain – board resolutions, shareholder approvals, and any required regulatory consents in the home jurisdiction – is complete and documented.
- The issuer has identified and briefed Swiss legal counsel, auditors, and, where applicable, underwriters at least four months before the target listing date.
- The issuer has assessed the interaction between Swiss financial markets legislation and the regulatory requirements of any other jurisdiction in which it operates or in which its securities will be offered.
Before submitting a prospectus for review, issuers should verify:
- All financial statements are audited and the audit opinion is unconditional.
- The prospectus satisfies the language requirements applicable to the target exchange segment.
- Insider trading and market conduct compliance procedures are in place and understood by senior management.
- Ongoing disclosure procedures – including ad hoc publicity – are prepared for activation from the first day of trading.
- The withholding tax position of target investor categories has been analysed and disclosed.
If the intended transaction involves distribution of securities to investors in EU member states. The issuer should also determine whether a separate EU prospectus is required and whether the Swiss and EU review processes can be coordinated in parallel. A delay in one process that is not anticipated in the timeline will affect the other.
A helpful starting point for companies still assessing their Swiss corporate structure is our guide to company formation in Switzerland, which addresses the foundational AG and GmbH formation steps that precede any capital markets transaction.
Frequently asked questions
- How long does a Swiss IPO take from start to first trading day?
- For a well-prepared issuer with audited financials and a complete corporate authorisation chain, the process from initial mandate to first trading day on the SIX Swiss Exchange typically takes between four and six months. Complex group structures, missing financial documentation, or regulatory consents required in a foreign home jurisdiction can extend this timeline significantly. Engaging Swiss legal counsel and auditors at least four months before the target listing date is the minimum prudent planning horizon.
- Can an EU-approved prospectus be used for a Swiss offering without re-approval?
- No. Switzerland is not part of the EU prospectus passporting system. A prospectus approved by a national competent authority within the EU – including the Portuguese securities regulator – cannot be used in Switzerland without separate approval from the competent Swiss reviewing body. The Swiss document must satisfy Swiss financial markets legislation requirements, which differ from the EU Prospectus Regulation in several respects. Issuers planning a dual listing in Switzerland and an EU market should budget for two separate review processes and allow for the possibility that they will not conclude simultaneously.
- Is it true that private placements in Switzerland require no prospectus at all?
- This is a common misconception. A private placement to qualified investors in Switzerland can be conducted without a full prospectus under certain conditions set out in Swiss financial markets legislation. primarily. That the offering is genuinely restricted to institutional or professional investors as defined under Swiss law. However, even a prospectus-exempt placement requires a compliant information memorandum, investor categorisation procedures, and adherence to Swiss market conduct rules. Issuers who assume that a private placement carries no regulatory burden regularly encounter compliance issues when FINMA examines the conduct of the offering.
About Ferraz & Whitmore
Ferraz & Whitmore is an international law firm based in Lisbon, advising business clients across 46 jurisdictions. Our capital markets practice supports international issuers, fund managers. Additionally. Institutional investors through every stage of a Swiss capital markets transaction. from initial structuring and prospectus preparation through to listing, ongoing disclosure, and post-transaction enforcement matters. The firm combines Portuguese civil law expertise with English common law tradition, giving our clients a practical understanding of both the Swiss civil law environment and the common law standards expected by international investors. As a law firm operating across Switzerland, Portugal, and the broader EU, Ferraz & Whitmore regularly coordinates dual-jurisdiction capital markets transactions where Swiss and EU regulatory processes must run in parallel. Engaging a lawyer in Switzerland with cross-border experience in EU and civil law systems significantly reduces the risk of procedural misalignment between the two review processes. Our attorneys have advised on equity and debt capital markets matters across civil law and common law systems, and our Lisbon base provides direct access to Portuguese and EU regulatory contacts. To discuss how Swiss capital markets law applies to your transaction, contact us at info@ferrazwhitmore.com.
Disclaimer: This publication is provided for informational purposes only and does not constitute legal advice. The information herein should not be relied upon as a substitute for professional legal counsel tailored to your specific circumstances. Ferraz & Whitmore assumes no liability for actions taken or not taken based on the contents of this material. For advice regarding your particular situation, please contact info@ferrazwhitmore.com.